Login / Signup

Six Years Follow-Up of an 11-Year-Old Girl with Anti-HMGCR Myopathy.

Dilek CavusogluBeril TalimGazanfer EkinciHaluk Topaloglu
Published in: Journal of neuromuscular diseases (2024)
Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level. In pediatric population, anti-HMGCR myopathy has been reported solely as small case reports, albeit rare. Although treatment consensus has not yet been established, proper treatment with several immunomodulators to include IVIg can show remarkable improvement. We report an 11-year-old-girl diagnosed with anti-HMGCR myopathy with 6 years of follow-up.
Keyphrases
  • late onset
  • muscular dystrophy
  • multiple sclerosis
  • early onset
  • case report
  • combination therapy
  • clinical practice
  • replacement therapy